BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30576868)

  • 1. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.
    Tang G; Hu S; Wang SA; Xie W; Lin P; Xu J; Toruner G; Zhao M; Gu J; Doty M; Li S; Medeiros LJ; Tang Z
    J Mol Diagn; 2019 Mar; 21(2):343-351. PubMed ID: 30576868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
    Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
    Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review.
    Smith SC; Qdaisat TZS; Althof PA; Dave BJ; Sanmann JN
    Leuk Res; 2020 Aug; 95():106387. PubMed ID: 32535247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities.
    Ronaghy A; Hu S; Tang Z; Wang W; Tang G; Loghavi S; Li S; Thakral B; Medeiros LJ; Muzzafar T
    Mod Pathol; 2021 Feb; 34(2):300-313. PubMed ID: 33110238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Genomic Profiles of Korean Patients with
    Lee J; Kim SM; Kim S; Yun J; Jeong D; Lee YE; Roh EY; Lee DS
    Ann Lab Med; 2022 Sep; 42(5):590-596. PubMed ID: 35470277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24).
    Lin P; Lennon PA; Yin CC; Abruzzo LV
    Cancer Genet Cytogenet; 2009 Sep; 193(2):119-22. PubMed ID: 19665075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
    Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R
    Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
    Gao J; Gurbuxani S; Zak T; Kocherginsky M; Ji P; Wehbe F; Chen Q; Chen YH; Lu X; Jennings L; Frankfurt O; Altman J; Sukhanova M
    Genes Chromosomes Cancer; 2022 Feb; 61(2):71-80. PubMed ID: 34668265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.
    Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R
    Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular approaches identify a cryptic MECOM rearrangement in a child with a rapidly progressive myeloid neoplasm.
    Capela de Matos RR; Othman MAK; Ferreira GM; Costa ES; Melo JB; Carreira IM; de Souza MT; Lopes BA; Emerenciano M; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Cancer Genet; 2018 Feb; 221():25-30. PubMed ID: 29405993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms.
    Hu Z; Medeiros LJ; Wang W; Chen Z; Tang G; Hodjat P; Yang S; Fang L; Li Y; Verstovsek S; Hu S
    Mod Pathol; 2017 Jul; 30(7):940-951. PubMed ID: 28338652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
    Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
    Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
    Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms.
    George TI; Bajel A
    Pathology; 2021 Apr; 53(3):312-327. PubMed ID: 33676766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations.
    Tang Z; Tang G; Hu S; Patel KP; Yin CC; Wang W; Lin P; Toruner GA; Ok CY; Gu J; Lu X; Khoury JD; Medeiros LJ
    Cancer Genet; 2019 Apr; 233-234():21-31. PubMed ID: 31109591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24).
    Lennon PA; Abruzzo LV; Medeiros LJ; Cromwell C; Zhang X; Yin CC; Kornblau SM; Konopieva M; Lin P
    Cancer Genet Cytogenet; 2007 Aug; 177(1):37-42. PubMed ID: 17693189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of both double minute of C-MYC and BCL-2 rearrangement containing large B-cell lymphoma with subsequent unfortunate development of therapy-related acute myeloid leukemia with t(3;3)(q26.2;q21).
    Nguyen JC; Kubik MJ; Broome HE; Curtin PT; Dell'Aquila ML; Wang HY
    Pathol Res Pract; 2015 Nov; 211(11):883-91. PubMed ID: 26300063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
    Wang HY; Rashidi HH
    Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
    Lin P; Medeiros LJ; Yin CC; Abruzzo LV
    Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.